NCT00740064View on ClinicalTrials.gov

Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects

PHASE4UnknownINTERVENTIONAL

Enrollment

30

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

November 30, 2009

Conditions

HIV Infections

Interventions

DRUG

Raltegravir and Abacavir/Lamivudine

Raltegravir 400mg BID Abacavir/Lamivudine 1 tablet QD

Trial Locations (3)

80220

Denver Infectious Disease Consultants, PLLC, Denver

85012

Spectrum Medical Group, Phoenix

87505-4765

Southwest CARE Center, Santa Fe

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Denver Infectious Disease Consultants, PLLC

OTHER